Background Strong immunosuppression, including chemotherapy and immune-depleting
antibodies followed by autologous haemopoietic stem-cell transplantation (aHSCT), has been …

Background Early diagnosis of sepsis enables timely resuscitation and antibiotics and
prevents subsequent morbidity and mortality. Clinical approaches relying on point-in-time …

Importance Systemic chemotherapy can be administered either through a peripheral vein (IV),
or centrally through peripherally inserted central catheter (PICC), totally implanted …

INTRODUCTION: The incidence of symptomatic catheter-related deep vein thrombosis (DVT)
in cancer patients remains unclear and there is a lack of reliable data on the risk factors of …

Importance Some patients with myasthenia gravis (MG) do not respond to conventional
treatment and have severe or life-threatening symptoms. Alternate and emerging therapies have …

Introduction The true incidence of symptomatic implanted port related venous thromboembolism
(VTE) in cancer patients is unclear and there is very limited data on its associated risk …

… Contributors: Sheryl McDiarmid conceived and designed the study, provided oversight for
data collection and analysis, and was the primary author of the manuscript. Nicholas Scrivens …

Full article: Comparison of complication rates and incidences associated with different
peripherally inserted central catheters (PICC) in patients with hematological malignancies: a …

Patients with coexisting medical problems may suffer increased toxicity and reduced quality
of life after autologous hematopoietic stem cell transplantation (HSCT). The benefit of high-…

Hematopoietic stem cell transplantation (HSCT) recipients are a high-risk, immunocompromised
group of patients who receive frequent transfusions after transplantation. Transfusion of …